Marlin-1 inhibitors belong to a distinct chemical class that has garnered significant attention in the field of molecular research. Marlin-1, also known as MARCKS-related protein, plays a crucial role in cellular signaling and cytoskeletal dynamics. The inhibitors targeting Marlin-1 are designed to modulate its activity, influencing downstream cellular processes. Structurally, these inhibitors typically exhibit a unique configuration that allows them to interact specifically with Marlin-1, disrupting its normal function.
The primary focus of Marlin-1 inhibitors is to impede the interaction between Marlin-1 and its binding partners, which are involved in intricate cellular pathways. By obstructing these interactions, Marlin-1 inhibitors may exert regulatory effects on cellular processes such as cell adhesion, migration, and signaling cascades. The development and study of Marlin-1 inhibitors represent a promising avenue for unraveling the complexities of intracellular communication and cellular motility. Researchers are actively exploring the structural and functional aspects of these inhibitors to elucidate their precise mechanisms of action and potential applications in manipulating cellular behavior. As investigations progress, the intricate details of Marlin-1 inhibitors continue to unfold, providing valuable insights into the fundamental processes governing cell biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Marlin-1 function is associated with JAK/STAT signaling, and by inhibiting protein kinases, Staurosporine can prevent phosphorylation events essential for signal transduction, thereby indirectly inhibiting Marlin-1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K). PI3K signaling is crucial for many cellular processes, including some that may involve Marlin-1. By inhibiting PI3K, LY294002 can reduce downstream signaling events that could indirectly inhibit the functional activity of Marlin-1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that works by binding to the catalytic site of the enzyme, thereby inhibiting its activity. Reduced PI3K activity leads to a decrease in AKT phosphorylation, a kinase that might interact with Marlin-1 signaling pathways, thus indirectly decreasing Marlin-1 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin specifically inhibits the mTOR (mammalian target of rapamycin) pathway, which is involved in cell growth and proliferation. By inhibiting mTOR, Rapamycin can decrease protein synthesis and cellular responses that may involve Marlin-1, leading to its functional inhibition. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which functions upstream of ERK in the MAPK pathway. Since Marlin-1 might interact with components of the MAPK pathway, inhibiting MEK could result in reduced ERK activity, potentially decreasing Marlin-1-mediated signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is also a MEK inhibitor that prevents the activation of MAPK/ERK, thereby inhibiting downstream signaling that could involve Marlin-1. This leads to a decrease in Marlin-1's functional activity as the MAPK pathway is crucial for various cellular responses. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase. By inhibiting p38 MAP kinase, SB203580 can block the response to stress stimuli that may otherwise activate Marlin-1. This inhibition could prevent Marlin-1 from fulfilling its role in cellular stress responses. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK pathway. Inhibition of JNK activity can lead to reduced transcriptional activity of AP-1, which might be involved in the regulation of Marlin-1, thus leading to the indirect inhibition of Marlin-1 activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-κB by blocking the phosphorylation of IκBα. Since NF-κB can regulate the expression of various proteins, including those that may interact with Marlin-1, inhibition of NF-κB can lead to decreased Marlin-1 activity. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor, primarily known for inhibiting BCR-ABL. It also affects other tyrosine kinases, which could be involved in signaling pathways that Marlin-1 participates in. By inhibiting these kinases, Imatinib could indirectly decrease Marlin-1 activity. | ||||||